[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567940":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":23,"collaborators":7,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":7,"eligibilityCriteria":33,"healthyVolunteers":34,"sex":35,"minAge":36,"maxAge":37,"enrollmentInfo":38,"targetDuration":36,"studyType":41,"phases":7,"briefSummary":42,"conditions":43,"keywords":7,"overallStatus":46,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Mohammed Ahmed Salem, Professor","Assuit University hospital","STUDY_DIRECTOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Esraa A Mohamed, Bachelor's","CONTACT","+201122736706","esraa.aboalqasem@gmail.com",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Mohamed O Gad, Professor","+201227006258","Omargad@gmail.com",{"type":24,"investigatorFullName":25,"investigatorTitle":26,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Esraa Abo Alqasem Mohamed Abd Alnaser","Resident","100567940","it-is-accepted-that-adenoid-hypertrophy-is-related-to-otitis-media-with-effusion-incidence-better-understanding-of-the-correlation-between-the-relative-size-of-ah-and-the-incidence-of-persistent-ome-may-provide-evidence-to-support-a-more-standardized-approach-to-the-diagnosis-and-treatment-of-ome-100567940",false,"NCT06674720","It is Accepted That Adenoid Hypertrophy is Related to Otitis Media With Effusion Incidence. Better Understanding of the Correlation Between the Relative Size of AH and the Incidence of Persistent OME May Provide Evidence to Support a More Standardized Approach to the Diagnosis and Treatment of OME.","Correlation of Site and Size of Adenoid Hypertrophy and Middle Ear Effusion.","Inclusion Criteria:\n\n* Children (until age of 16 years old).\n* Patients with adenoid hypertrophy.\n* Patients with OME.\n\nExclusion Criteria:\n\n* Children known to have cleft palate, submucous cleft palate or other medical problems causing velopharyngeal insufficiency.\n* Down's syndrome, septal deviation, primary ciliary dyskinesia (Kartagener's syndrome), previous head or ear trauma, or previous myringotomy with ventilation tube insertion\n* Systemic medical problems interfering with surgery.\n* Refusal of parents to participate.\n* Craniofacial abnormalities.",true,"ALL","1 Year","16 Years",{"count":39,"type":40},60,"ESTIMATED","OBSERVATIONAL","The aim of this study is to further investigate the correlation between Site and size of adenoid hypertrophy and middle ear effusion in order to provide evidence for designing a more standardized approach to the diagnosis and treatment of OME.",[44,45],"Adenoid Hypertrophy","Middle Ear Effusion","NOT_YET_RECRUITING","2025-01-16",{"date":49,"type":50},"2025-01-17","ACTUAL",{"date":52,"type":40},"2025-05",{"date":54,"type":40},"2027-12",{"name":5,"class":6}]